Condition: Hidradenitis Suppurativa · Sponsor: Sanofi
This is a multinational, randomized, double-blind, placebo-controlled, Phase 2, dose finding study to evaluate the efficacy and safety of different doses of SAR445399 in adult participants with moderate to severe hidradenitis suppurativa. The purpose of this study is to assess the efficacy and safety of two doses of SAR445399 compared with placebo in adult participants with moderate to severe hidradenitis suppurativa. The study duration (per participant) will be up to 46 weeks with a total of 16 visits. The treatment duration will be 32 weeks which includes 16-week double-blinded initial treatment period and a 16-week treatment-blinded extension period.
This description comes directly from the study's public registry record.
Trial Transparency email recommended (Toll free for US & Canada) · 800-633-1610 · Contact-US@sanofi.com
Always discuss trial participation with your own doctor first.
| Scottsdale Clinical Trials- Site Number : 8400006 | Scottsdale, Arizona, United States | Recruiting |
| Carbon Health - North Hollywood - NoHo West- Site Number : 8400017 | North Hollywood, California, United States | Recruiting |
| Encore Medical Research of Boynton Beach- Site Number : 8400005 | Boynton Beach, Florida, United States | Recruiting |
| FXM Clinical Research - Fort Lauderdale- Site Number : 8400013 | Fort Lauderdale, Florida, United States | Recruiting |
| Alliance for Multispeciality Research - Fort Myers- Site Number : 8400007 | Fort Myers, Florida, United States | Recruiting |
| Encore Medical Research - Hollywood- Site Number : 8400004 | Hollywood, Florida, United States | Recruiting |
| Fxm Clinical Research/Fax Pharma Clinical Research- Site Number : 8400014 | Miami, Florida, United States | Recruiting |
| Florida International Research Center- Site Number : 8400002 | Miami, Florida, United States | Recruiting |
| Florida Research Center- Site Number : 8400009 | Miami, Florida, United States | Recruiting |
| Advanced Clinical Research Institute- Site Number : 8400021 | Tampa, Florida, United States | Recruiting |
| Cleaver Medical Group Dermatology- Site Number : 8400008 | Cumming, Georgia, United States | Recruiting |
| First Georgia Physician Group- Site Number : 8400033 | Fayetteville, Georgia, United States | Recruiting |
+ 54 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07225569